Karla Jarvis
Family · Louisville, KYNPI 1750634093
Payments from drug & device makers
Across 259 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$584
- AstraZeneca$509
- Novo Nordisk$315
- Bayer$297
- Lilly USA, LLC$274
- GSK$258
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,847100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $584 |
| AstraZeneca | 32 | $509 |
| Novo Nordisk | 23 | $315 |
| Bayer | 18 | $297 |
| Lilly USA, LLC | 19 | $274 |
| GSK | 19 | $258 |
| Currax Pharmaceuticals LLC | 20 | $248 |
| Shield Therapeutics Inc | 17 | $224 |
| Pfizer | 12 | $214 |
| Amgen | 6 | $95 |
| Antares Pharma, Inc. | 4 | $80 |
| Exact Sciences | 4 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $73 |
| Merz North America, Inc. | 1 | $72 |
| Medtronic | 3 | $69 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $57 |
| Sunovion Pharmaceuticals Inc. | 3 | $49 |
| Boehringer Ingelheim | 3 | $49 |
| Esperion Therapeutics, Inc. | 3 | $48 |
| Idorsia Pharmaceuticals US Inc | 2 | $38 |
| Endo Pharmaceuticals Inc. | 2 | $33 |
| Abbott | 2 | $32 |
| Clarus Therapeutics Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Optinose US, Inc. | 1 | $19 |
| Virtus Pharmaceuticals LLC | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Scynexis, Inc. | 1 | $12 |
How this compares
$3,858 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 29 | $28,347 |
| FarxigaDapagliflozin Propanediol | 26 | $20,006 |
| TrulicityDulaglutide | 18 | $15,126 |
| OzempicSemaglutide | 16 | $14,295 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $12,964 |
| Nurtec OdtRimegepant Sulfate | 13 | $11,611 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $790 |
| Metoprolol Succinate | 29 | $497 |
| Azelastine Hcl | 18 | $430 |
| Hydroxyzine Hcl | 16 | $422 |
| Montelukast Sodium | 33 | $345 |
| Omeprazole | 22 | $292 |
| Levocetirizine Dihydrochloride | 15 | $281 |
| Potassium Chloride | 14 | $260 |
| Levothyroxine Sodium | 25 | $258 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $274 | $43,47247 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $509 | $32,97048 claims |
| Novo NordiskOzempic | $315 | $14,29516 claims |
| PfizerNurtec Odt | $214 | $11,61113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.
Other family in Louisville
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Shelley WaldmanLouisville$59K
- Esther MuhsLouisville$44K
- Barbra CaveLouisville$41K
- Kayla WilsonLouisville$40K
- Christin ThompsonLouisville$38K
- Wendi HallerLouisville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.